4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-016074
Director sold 59,240 shares at an average $12.50 ($740,658)
- Director acquired 156,679 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal Director | 2023-03-01 | Option exercise | +96,150 | 1,271,913 | D | ||
| Walker Neal Director | 2023-03-01 | Option exercise | +18,275 | 1,290,188 | D | ||
| Walker Neal Director | 2023-03-01 | Option exercise | +24,000 | 1,314,188 | D | ||
| Walker Neal Director | 2023-03-02 | Sale | −29,000 | $12.37 | $358,588 | 1,285,188 | D |
| Walker Neal Director | 2023-03-02 | Option exercise | +18,254 | 1,303,442 | D | ||
| Walker Neal Director | 2023-03-03 | Sale | −30,240 | $12.63 | $382,070 | 1,273,202 | D |
| Derivatives | |||||||
| Walker Neal Director | 2023-03-01 | Option exercise · Restricted Stock Units | −96,150 | 0 | D | ||
| Walker Neal Director | 2023-03-01 | Option exercise · Restricted Stock Units | −18,275 | 36,550 | D | ||
| Walker Neal Director | 2023-03-01 | Option exercise · Restricted Stock Units | −24,000 | 72,000 | D | ||
| Walker Neal Director | 2023-03-02 | Option exercise · Restricted Stock Units | −18,254 | 18,254 | D | ||
| Open-market sales · 59,240 sh · avg $12.50 · $740,658 | |||||||
Loading xslF345X03/doc4.xml…